Male Hypogonadism - Drug Pipeline Landscape, 2023

Male Hypogonadism is characterized by a decrease in testosterone level or lack of spermatozoa production or both. When a disorder related to the testes it is called primary hypogonadism or if it related to the hypothalamic-pituitary axis it is called secondary hypogonadism.

Causes of hypogonadism include HIV or AIDS, Klinefelter syndrome, Kallmann syndrome, injury to testicles, and untreated sleep apnea.

To Remain 'Ahead' Of Your Competitors, Request for A Sample: https://www.globalinsightservices.com/request-sample/GIS31269

Symptoms of hypogonadism include fatigue, hot flashes, infertility, decrease in muscle mass, and loss of bone mass Doctor diagnose hypogonadism based on a physical exam, a review of symptoms, and the results of multiple blood tests which will detect low testosterone levels.

Male hypogonadism is usually treated with testosterone replacement to return testosterone levels to normal and natural therapies which will increase testosterone production including diet and exercise, weight loss, improved sleep.

Read more about Male Hypogonadism - Drug Pipeline here: https://www.globalinsightservices.com/reports/male-hypogonadism-drug-pipeline-landscape-2022

Report Highlights
Global Insight Service's, Male Hypogonadism - Drug Pipeline Landscape, 2023 report provides an overview of the Male Hypogonadism pipeline drugs. This report covers detailed insights on Male Hypogonadism drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Male Hypogonadism pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS31269

Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.

Major pharmaceutical companies are involved in the development of potential drug candidates to improve the Male Hypogonadism treatment such as Leflutrozole, LPCN-1111, Testagen and others. Key players involved in the development of therapies to treat Male Hypogonadism are Hypospraypharma, Mereo BioPharma, Lipocine Inc, Clarus Therapeutics Inc, Lennham Pharmaceuticals Inc and others. Three drugs are under late-stage Phase II clinical trials and five drugs are in Phase I clinical trials and some other drugs are under Preclinical stages of development.

For In-Depth Competitive Analysis, Purchase this Report: https://www.globalinsightservices.com/checkout/single_user/GIS31269

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.